miR-9 has an inhibitory role in papillary thyroid cancer by targeting BRAF and reduces metastatic behavior in triple-negative breast cancer by targeting NOTCH1 [39, 40]. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.